186 related articles for article (PubMed ID: 35854065)
41. Platelets promote breast cancer cell MCF-7 metastasis by direct interaction: surface integrin α2β1-contacting-mediated activation of Wnt-β-catenin pathway.
Zuo XX; Yang Y; Zhang Y; Zhang ZG; Wang XF; Shi YG
Cell Commun Signal; 2019 Nov; 17(1):142. PubMed ID: 31699102
[TBL] [Abstract][Full Text] [Related]
42. CCL4 Stimulates Cell Migration in Human Osteosarcoma via the mir-3927-3p/Integrin αvβ3 Axis.
Tsai HC; Lai YY; Hsu HC; Fong YC; Lien MY; Tang CH
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884541
[TBL] [Abstract][Full Text] [Related]
43. Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion.
Annis MG; Ouellet V; Rennhack JP; L'Esperance S; Rancourt C; Mes-Masson AM; Andrechek ER; Siegel PM
Breast Cancer Res; 2018 Jan; 20(1):9. PubMed ID: 29382358
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression.
Kong X; Li G; Yuan Y; He Y; Wu X; Zhang W; Wu Z; Chen T; Wu W; Lobie PE; Zhu T
PLoS One; 2012; 7(8):e41523. PubMed ID: 22876288
[TBL] [Abstract][Full Text] [Related]
45. The Effects of αvβ3 Integrin Blockage in Breast Tumor and Endothelial Cells under Hypoxia In Vitro.
Casali BC; Gozzer LT; Baptista MP; Altei WF; Selistre-de-Araújo HS
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163668
[TBL] [Abstract][Full Text] [Related]
46. BSP gene silencing inhibits migration, invasion, and bone metastasis of MDA-MB-231BO human breast cancer cells.
Wang J; Wang L; Xia B; Yang C; Lai H; Chen X
PLoS One; 2013; 8(5):e62936. PubMed ID: 23667544
[TBL] [Abstract][Full Text] [Related]
47. Disintegrin Tablysin-15 Suppresses Cancer Hallmarks in Melanoma Cells by Blocking FAK/Akt/ERK and NF-κB Signaling.
Deng Z; Zeng Q; Chai J; Zhang B; Zheng W; Xu X; Wu J
Curr Cancer Drug Targets; 2020; 20(4):306-315. PubMed ID: 31893992
[TBL] [Abstract][Full Text] [Related]
48. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases.
Zhao Y; Bachelier R; Treilleux I; Pujuguet P; Peyruchaud O; Baron R; Clément-Lacroix P; Clézardin P
Cancer Res; 2007 Jun; 67(12):5821-30. PubMed ID: 17575150
[TBL] [Abstract][Full Text] [Related]
49. Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation.
Feng MX; Ma MZ; Fu Y; Li J; Wang T; Xue F; Zhang JJ; Qin WX; Gu JR; Zhang ZG; Xia Q
Mol Cancer; 2014 Oct; 13():226. PubMed ID: 25273699
[TBL] [Abstract][Full Text] [Related]
50. CCL2 increases αvβ3 integrin expression and subsequently promotes prostate cancer migration.
Lin TH; Liu HH; Tsai TH; Chen CC; Hsieh TF; Lee SS; Lee YJ; Chen WC; Tang CH
Biochim Biophys Acta; 2013 Oct; 1830(10):4917-27. PubMed ID: 23845726
[TBL] [Abstract][Full Text] [Related]
51.
Zhang J; Mao F; Niu G; Peng L; Lang L; Li F; Ying H; Wu H; Pan B; Zhu Z; Chen X
Theranostics; 2018; 8(4):1121-1130. PubMed ID: 29464003
[No Abstract] [Full Text] [Related]
52. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
53. AKR1B10 promotes breast cancer metastasis through integrin α5/δ-catenin mediated FAK/Src/Rac1 signaling pathway.
Huang C; Verhulst S; Shen Y; Bu Y; Cao Y; He Y; Wang Y; Huang D; Cai C; Rao K; Liao DF; Jin J; Cao D
Oncotarget; 2016 Jul; 7(28):43779-43791. PubMed ID: 27248472
[TBL] [Abstract][Full Text] [Related]
54. Role of LGMN in tumor development and its progression and connection with the tumor microenvironment.
Khan SU; Khan IM; Khan MU; Ud Din MA; Khan MZ; Khan NM; Liu Y
Front Mol Biosci; 2023; 10():1121964. PubMed ID: 36825203
[TBL] [Abstract][Full Text] [Related]
55. Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells.
Montenegro CF; Salla-Pontes CL; Ribeiro JU; Machado AZ; Ramos RF; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
Biochimie; 2012 Aug; 94(8):1812-20. PubMed ID: 22561350
[TBL] [Abstract][Full Text] [Related]
56. Thyroid Hormone Controls Breast Cancer Cell Movement via Integrin αV/β3/SRC/FAK/PI3-Kinases.
Flamini MI; Uzair ID; Pennacchio GE; Neira FJ; Mondaca JM; Cuello-Carrión FD; Jahn GA; Simoncini T; Sanchez AM
Horm Cancer; 2017 Feb; 8(1):16-27. PubMed ID: 28050799
[TBL] [Abstract][Full Text] [Related]
57. Molecular Imaging of Breast Cancer: Role of RGD Peptides.
Chakravarty R; Chakraborty S; Dash A
Mini Rev Med Chem; 2015; 15(13):1073-94. PubMed ID: 26349490
[TBL] [Abstract][Full Text] [Related]
58. Membrane type-1 matrix metalloproteinase (MT1-MMP) processing of pro-alphav integrin regulates cross-talk between alphavbeta3 and alpha2beta1 integrins in breast carcinoma cells.
Baciu PC; Suleiman EA; Deryugina EI; Strongin AY
Exp Cell Res; 2003 Nov; 291(1):167-75. PubMed ID: 14597417
[TBL] [Abstract][Full Text] [Related]
59. Alternative splicing of KAI1 abrogates its tumor-suppressive effects on integrin αvβ3-mediated ovarian cancer biology.
Upheber S; Karle A; Miller J; Schlaugk S; Gross E; Reuning U
Cell Signal; 2015 Mar; 27(3):652-62. PubMed ID: 25435431
[TBL] [Abstract][Full Text] [Related]
60. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
Chen YJ; Wei YY; Chen HT; Fong YC; Hsu CJ; Tsai CH; Hsu HC; Liu SH; Tang CH
J Cell Physiol; 2009 Oct; 221(1):98-108. PubMed ID: 19475568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
